2023
Unlocking the Proteome - The NULISA™ Platform
Entrant Company
Halteres Associates
Category
Video, Commercial & Film - Medical
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
MI Health Agency
Category
Video, Commercial & Film - Public Service & Activism
Country / Region
Ukraine
Entrant Company
Public Health Musings Podcast
Category
Strategic Program - Healthcare Campaign
Country / Region
United States
Entrant Company
Halteres Associates
Category
Social Media - Interview / Talk Show
Country / Region
United States
Entrant Company
American Kidney Fund
Category
Video, Commercial & Film - Educational
Country / Region
United States